According to a recent report published in The Lancet, the global incidence of prostate cancer is projected to more than double by 2040, as developing countries catch up with the aging population of wealthier nations.
The study, which examined demographic changes, predicts a significant rise in new cases from 1.4 million in 2020 to a staggering 2.9 million by 2040.
Prostate cancer is already the most prevalent cancer among men, accounting for approximately 15 percent of all cancer cases. It typically manifests after the age of 50 and becomes more common as men grow older. However, as life expectancy improves in developing nations, the incidence of prostate cancer is also on the rise, according to the researchers.
Unlike diseases such as lung cancer or heart disease, which can be influenced by public health policies, the researchers emphasize that prostate cancer’s increase is primarily driven by factors like increased longevity and changes in the global age distribution. While hereditary factors play a role, they are less manageable compared to lifestyle factors like smoking, which is a known cause of lung cancer. The correlation between weight and prostate cancer has been established, although it is yet to be determined if it directly causes the disease.
The study also highlights the need for early screening initiatives in developing countries, as late diagnosis often hampers effective treatment. Public health authorities are urged to prioritize proactive measures to detect prostate cancer at its earliest stages, thereby improving the chances of successful intervention.
Source: AFP
